PARIS -- The early commercial experience with transcatheter aortic valve replacement (TAVR or TAVI) for severe aortic regurgitation appeared promising, though device size issues and conduction ...
NEW YORK, NY—For patients with pure native aortic regurgitation (AR) who are undergoing TAVI, use of devices tailored to treat the AR seems to provide superior outcomes compared with off-label use of ...
Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had an overall mortality rate of just 8.1% at one year, well below the trial's ...
The FDA has given thumbs up to two clinical studies for a transcatheter aortic valve replacement (TAVR) system developed by HLT Inc. to treat aortic stenosis among high-risk patients. Those studies ...
HONG KONG, Dec. 12, 2025 /PRNewswire/ -- Peijia Medical (9996.HK), a leading Chinese domestic company in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, ...
Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure to replace your aortic valve. The aortic valve controls blood flow from your heart to your aorta, the main artery that ...
When a heart valve is damaged or doesn’t close properly, it can cause what’s known as a “leaky valve.” Depending on the severity of the leaky valve, there are several different treatment options, ...
There are three types of bicuspid aortic valves — types 0, 1, and 2. Experts classify these types based on whether the leaflets of the valve have fused to form a ridge. A bicuspid aortic valve is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback